PK and Safety of Dapivirine-Levonorgestrel Vaginal Ring in Healthy Women

Phase 1, randomised, open-label trial of dapivirine and avatrombopag in human immunodeficiency virus infection (HIV) and contraception (2 arms), sponsored by International Partnership for Microbicides. Primary endpoints: Change in baseline of DPV and LNG concentrations in plasma at 90 days, Change in baseline of DPV and LNG concentrations in cervicovaginal fluid at 90 days and 1 more. Started Jul 2018; status: completed.